Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

Õý´óÌìÇçPD-L1µ¥¿¹TQB2450ÐÂ˳Ӧ֢ÄâÄÉÈëÓÅÏÈÉóÆÀ

2024-02-02
|
»á¼ûÁ¿£º

΢ÐÅͼƬ_20240129172002.jpg

Ò½ÏßÒ©ÎÅ

1. 1ÔÂ31ÈÕ£¬£¬£¬£¬£¬CDEÍøÕ¾ÏÔʾ£¬£¬£¬£¬£¬Õý´óÌìÇçPD-L1µ¥¿¹TQB2450£¨±´ÄªËհݵ¥¿¹£©µÄÐÂ˳Ӧ֢ÄâÄÉÈëÓÅÏÈÉóÆÀ£¬£¬£¬£¬£¬ÓÃÓÚÁªºÏÑÎËá°²ÂÞÌæÄὺÄÒÖÎÁƼÈÍù½ÓÊÜÒ»¡¢¶þÏß»¯ÁƼƻ®ÖÎÁÆÊ§°Ü»ò²»¿ÉÄÍÊܵķÇ΢ÎÀÐǸ߶Ȳ»Îȹ̣¨·ÇMSI-H£©»ò·ÇDNA´íÅäÐÞ¸´È±ÏÝ£¨·ÇdMMR£©µÄ¸´·¢ÐÔ»ò×ªÒÆÐÔ×Ó¹¬ÄÚĤ°©»¼Õß¡£¡£¡£¡£

2. 1ÔÂ31ÈÕ£¬£¬£¬£¬£¬NMPA¹ÙÍøÐû²¼Åú×¼ºãÈðÒ½Ò©1ÀàÁ¢ÒìÒ©¸»ÂíËáÌ©¼ªÏ鶨עÉäÒºÉÏÊУ¬£¬£¬£¬£¬ÊÊÓÃÓÚ¸¹²¿ÊÖÊõºóÖÐÖØ¶ÈÌÛÍ´¡£¡£¡£¡£Æ¾Ö¤ºãÈðÒ½Ò©ÔçÏÈÐÂΟ壬£¬£¬£¬£¬Ì©¼ªÏ鶨£¨SHR8554×¢ÉäÒº£©ÊÇÒ»¿î°ÐÏò¦Ì°¢Æ¬ÊÜÌ壨MOR£©µÄС·Ö×ÓÒ©Îï¡£¡£¡£¡£

3. 1ÔÂ31ÈÕ£¬£¬£¬£¬£¬Ê¯ËÄÒ©¼¯ÍÅÐû²¼Í¨¸æÐû²¼£¬£¬£¬£¬£¬ÑÎËáÒì±ûÉöÉÏÏÙËØÒÑ»ñ¹ú¼ÒÒ©¼à¾ÖÅú×¼¹ÒºÅ³ÉΪÔÚÉÏÊÐÖÆ¼ÁʹÓõÄÖÊÁÏÒ©£¬£¬£¬£¬£¬ÕâÊǺ£ÄÚµÚ¶þ¼Ò»ñÅúµÄÆóÒµ¡£¡£¡£¡£ÑÎËáÒì±ûÉöÉÏÏÙËØÊǦÂÊÜÌ弤¶¯¼Á£¬£¬£¬£¬£¬Ö÷ÒªÓÃÓÚÖÎÁÆÖ§Æø¹ÜÏø´­¼°ÐÄÔà·¿ÊÒ´«µ¼×èÖÍ¡£¡£¡£¡£

4. 1ÔÂ31ÈÕ£¬£¬£¬£¬£¬¹þÒ©¹É·Ýͨ¸æ£¬£¬£¬£¬£¬·Ö¹«Ë¾¹þÒ©×ܳ§Ò©Æ·×¢ÉäÓÃÍ·æßÇúËÉÄÆÍ¨¹ý·ÂÖÆÒ©Ò»ÖÂÐÔÆÀ¼Û¡£¡£¡£¡£¸ÃҩΪµÚÈý´ú×¢ÉäÓÃÍ·æß¾úËØ£¬£¬£¬£¬£¬ÊÊÓÃÓÚ¶ÔÍ·æßÇúËÉÃô¸ÐµÄÖ²¡¾úÒýÆðµÄѬȾ¡£¡£¡£¡£

ͶÈÚÒ©ÊÂ

1. Vaxcyte¹«Ë¾ÈÕǰÐû²¼£¬£¬£¬£¬£¬½«Í¨¹ý¹ûȻļ¹ÉÈÚ×Ê7.5ÒÚÃÀÔª£¬£¬£¬£¬£¬ÓÃÓÚÖ§³ÖÆäÁ¢Òìϸ¾úѬȾ²¡ÒßÃçµÄ¿ª·¢¡£¡£¡£¡£¸Ã¹«Ë¾µÄÖ÷´òÔÚÑвúÆ·ÊÇÒ»¿î¹ãÆ×24¼Û·ÎÑ×Çò¾úÁ¬ÏµÒßÃ磨PCV£©VAX-24£¬£¬£¬£¬£¬ÓÃÓÚÔ¤·À·ÎÑ×Çò¾úÒýÆðµÄÇÖÏ®ÐÔ·ÎÑ×Á´Çò¾ú²¡£¡£¡£¡£¨IPD£©£¬£¬£¬£¬£¬°üÀ¨ÄÔĤÑ׺ͰÜѪ֢£¬£¬£¬£¬£¬ÒÔ¼°·ÇÇÖÏ®ÐÔ·ÎÑ×Á´Çò¾ú²¡£¡£¡£¡£¨PD£©£¬£¬£¬£¬£¬°üÀ¨·ÎÑס¢ÖжúÑ׺ͱÇñ¼Ñס£¡£¡£¡£

¿Æ¼¼Ò©ÑÐ

1. 1ÔÂ24ÈÕ£¬£¬£¬£¬£¬Âí¿Ë˹-ÆÕÀÊ¿ËÑо¿ËùDirk G?rlichÍŶӺÍÂéÊ¡Àí¹¤Ñ§ÔºThomas U. SchwartzÍŶӣ¨£©ÏàÖú£¬£¬£¬£¬£¬ÔÚ Nature ÆÚ¿¯½ÒÏþÁËÌâΪ£ºHIV-1 capsids enter the FG phase of nuclear pores like a transport receptor µÄÑо¿ÂÛÎÄ¡£¡£¡£¡£¸ÃÑо¿·¢Ã÷£¬£¬£¬£¬£¬HIV²¡¶¾Ò¿ÇÒѾ­½ø»¯³ÉÒ»ÖÖºËתÔËÂѰף¬£¬£¬£¬£¬Ëü¿ÉÒÔÖ±½ÓÍ»ÆÆ±£»£»£»£»£»¤Ï¸°ûºËÃâÊܲ¡¶¾ÈëÇÖµÄÖ÷ÒªÆÁÕÏ£¬£¬£¬£¬£¬²»ÒÀÀµºËתÔËÂѰ׶ø´©¹ýºË¿×½øÈëϸ°ûºË¡£¡£¡£¡£ÓÉÓÚHIV²¡¶¾»ùÒò×é±»Ò¿ÇÍêÈ«·â×°£¬£¬£¬£¬£¬ÕâҲʹµÃHIV»ùÒò×éÌÓ¹ýÈËÀàϸ°ûµÄϸ°ûÖÊÖеĿ¹²¡¶¾´«¸ÐÆ÷µÄʶ±ð£¬£¬£¬£¬£¬ÈÆÏ꾡°ûµÄ²¡¶¾·ÀÓùϵͳ£¬£¬£¬£¬£¬½«×Ô¼ºµÄÒÅ´«ÎïÖÊ¡°ÍµÔË¡±½øÏ¸°ûºË£¬£¬£¬£¬£¬²¢½øÒ»²½ÕûºÏµ½È¾É«ÌåÖС£¡£¡£¡£

[1] Fu, L., Weiskopf, E.N., Akkermans, O. et al. HIV-1 capsids enter the FG phase of nuclear pores like a transport receptor. Nature (2024

Ïà¹ØÐÂÎÅ
¿¹PD-1/PD-L1µ¥¿¹Æ·ÖÖÉ걨ÉÏÊеÄ×ÊÁÏÊý¾Ý»ù±¾ÒªÇóÐû²¼
2018-02-12
½ñÌ죬£¬£¬£¬£¬¹ú¼ÒʳÎïÒ©Æ·¼àÊÓ¹ÜÀí×ܾÖÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©·¢Îijƣ¬£¬£¬£¬£¬Æ¾Ö¤CDE×éÖ¯ÕÙ¿ªµÄ¿¹PD-1/PD-L1µ¥¿¹É걨×ÊÁÏÒªÇóרÌâ×êÑлáÉÏ£¬£¬£¬£¬£¬Óë»áÆóÒµ¡¢×¨¼ÒºÍCDEÉóÆÀÍŶÓÌÖÂ۸濢µÄ¹²Ê¶£¬£¬£¬£¬£¬ÏÖÔÚÒÑÐγÉÁË¿¹PD-1/PD-L1µ¥¿¹Æ·ÖÖÉ걨ÉÏÊеÄ×ÊÁÏÊý¾Ý»ù±¾ÒªÇ󣬣¬£¬£¬£¬¹©´ËÀàÒ©Æ·µÄÑз¢ºÍÉ걨×ÊÁÏ×¼±¸²Î¿¼¡£¡£¡£¡£
ºãÈðÒ½Ò©¿¹PD-L1µ¥¿¹¡¸°¢µÃ±´Àûµ¥¿¹¡¹»ñÅúÉÏÊÐØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2023-03-03
3ÔÂ3ÈÕ£¬£¬£¬£¬£¬Öйú¹ú¼ÒÒ©¼à¾Ö£¨NMPA£©¹ÙÍø¹«Ê¾£¬£¬£¬£¬£¬ºãÈðÒ½Ò©×ÔÖ÷Ñз¢µÄ¿¹PD-L1µ¥¿¹°¢µÃ±´Àûµ¥¿¹×¢ÉäÒºÒÑ»ñÅúÉÏÊС£¡£¡£¡£Æ¾Ö¤ºãÈðÒ½Ò©ÔçÏÈÐÂΟ壬£¬£¬£¬£¬¸ÃÒ©±¾´Î»ñÅúµÄ˳Ӧ֢Ϊ£ºÁªºÏ»¯ÁÆÒ»ÏßÖÎÁÆÆÕ±éÆÚСϸ°û·Î°©£¨ES-SCLC£©¡£¡£¡£¡£
Õý´óÌìÇ竱ÈǰÏßͪÈí½ºÄÒÄÃϺ£ÄÚÊ×·ÂØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2023-06-29
6ÔÂ29ÈÕ£¬£¬£¬£¬£¬ÄϾ©Õý´óÌìÇçÆìÏ«±ÈǰÏßͪÈí½ºÄÒ»ñ¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨NMPA£©Åú×¼£¬£¬£¬£¬£¬ÄÃϺ£ÄÚÊ׷¡£¡£¡£¡£Â³±ÈǰÏßͪ£¨¼´Â«±ÈǰÏßͪ£©ÎªÒ»ÖÖ´ÙÉøÍ¸Ò©Î£¬£¬£¬£¬¾ßÓкܺõıãÃØÖÎÁÆÐ§¹û¡£¡£¡£¡£
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿